Dergiler / Acta Medica / 2021 / Cilt: 52 - Sayı: 1

An Overview of Alpha Synuclein Protein and Its Role in Parkinson’s disease

Sayfa
1–10
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

It’s important to unravel the secrets of this protein and understand its behaviours in order to improve existing treatment protocols and also to develop new and more effective treatments for Parkinson’s Disease.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Parkinson’s disease is the most common age-related motor movement disorder.
📊
Temel Bulgular & Veri:The physiological and pathologic features of α-synuclein protein are reviewed based mostly upon review of the literature. α-synuclein has significant functions especially at central nervous system. α-synuclein is a protein that can be found in various areas within the cell, particularly in the presynaptic axon terminals.
💡
Sonuç & Katkı:It’s important to unravel the secrets of this protein and understand its behaviours in order to improve existing treatment protocols and also to develop new and more effective treatments for Parkinson’s Disease.
🔬Tür:Literatür & Derleme Çalışması
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Parkinson’s disease is the most common age-related motor movement disorder. Pathological changes in Parkinson’s disease are the loss of melanin-containing dopaminergic neurons and the detection of inclusion bodies in the cells, which contain alpha-synuclein and ubiquitinated proteins, called as Lewy bodies. In this review; the structure of Lewy bodies, structural features and intracellular localization of α-synuclein protein, intracellular functions and intercellular spread of α-synuclein protein are discussed. The physiological and pathologic features of α-synuclein protein are reviewed based mostly upon review of the literature. α-synuclein has significant functions especially at central nervous system. α-synuclein is a protein that can be found in various areas within the cell, particularly in the presynaptic axon terminals. Under pathologic conditions, cellular accumulation of misfolded α-synuclein oligomers and aggregates are observed in a group of neurodegenerative diseases called synucleinopathies. The mechanisms of how α-synuclein protein takes part in the neurodegeneration process and physiologic roles of the protein have not been fully elucidated yet. It’s important to unravel the secrets of this protein and understand its behaviours in order to improve existing treatment protocols and also to develop new and more effective treatments for Parkinson’s Disease.

🔖

Bu Makaleye Atıf Yap

KAYA, Z. B., ATILLA, P. (2021). An Overview of Alpha Synuclein Protein and Its Role in Parkinson’s disease. Acta Medica, Cilt: 52 - Sayı: 1, 1–10. https://ajindex.com/articles/217945

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

  1. Jellinger KA. Neuropathobiology of non-motor symptoms in Parkinson disease. Journal of Neural Transmission. 2015
  2. 122(10): 1429-1440. [2]Michel PP, Hirsch EC, Hunot S. Understanding dopaminergic cell death pathways in Parkinson disease. Neuron. 2016
  3. 90(4): 675-691. [3]Alberio T, Lopiano L, Fasano M. Cellular models to investigate biochemical pathways in Parkinson’s disease. FEBS Journal. 2012
  4. 279(7): 1146-1155. [4]Kaur K, Gill JS, Bansal PK, et al. Neuroinflammation-A major cause for striatal dopaminergic degeneration in Parkinson’s disease. Journal of the neurological sciences. 2017
  5. Engelhardt E, Gomes MdM. Lewy and his inclusion bodies: Discovery and rejection. Dementia & Neuropsychologia. 2017
  6. 11(2): 198-201. [6]Goedert M, Spillantini MG, Del Tredici K, et al. 100 years of Lewy pathology. Nature Reviews Neurology. 2013
  7. 9(1): 13. [7]Wakabayashi K, Tanji K, Odagiri S, et al. The Lewy body in Parkinson’s disease and related neurodegenerative disorders. Molecular neurobiology. 2013
  8. 47(2): 495-508. [8]Shahmoradian SH, Lewis AJ, Genoud C, et al. Lewy pathology in Parkinson’s disease consists of crowded organelles and lipid membranes. Nature neuroscience. 2019
  9. 22(7): 1099-1109. [9]Ubeda-Banon I, Saiz-Sanchez D, de la Rosa-Prieto C, et al. α-Synucleinopathy in the human olfactory system in Parkinson’s disease: involvement of calcium-binding protein-and substance P-positive cells. Acta neuropathologica. 2010
  10. 119(6): 723-735. [10]Langston JW, Forno LS. The hypothalamus in Parkinson disease. Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society. 1978
  11. 3(2): 129-133. [11]Homma T, Mochizuki Y, Mizutani T. Phosphorylated α‐synuclein immunoreactivity in the posterior pituitary lobe. Neuropathology. 2012
  12. 32(4): 385-389. [12]Braak H, Rueb U, Sandmann-Keil D, et al. Parkinson’s disease: affection of brain stem nuclei controlling premotor and motor neurons of the somatomotor system. Acta neuropathologica. 2000
  13. 99(5): 489-495. [13]Mori F, Piao Y-S, Hayashi S, et al. α-Synuclein accumulates in Purkinje cells in Lewy body disease but not in multiple system atrophy. Journal of Neuropathology & Experimental Neurology. 2003
  14. 62(8):812-819. [14]Braak H, Sastre M, Bohl JR, de Vos RA, et al. Parkinson’s disease: lesions in dorsal horn layer I, involvement of parasympathetic and sympathetic pre-and postganglionic neurons. Acta neuropathologica. 2007
  15. 113(4): 421-429. [15]Tamura T, Yoshida M, Hashi